纳特拉基因检测

最新新闻

• Citi Maintains Natera(NTRA.US) With Buy Rating, Raises Target Price to $480
  \u5e02\u573a\u8d44\u8baf · 2026/10/6
• 评级变动
  BTIG Maintains Natera(NTRA.US) With Buy Rating, Raises Target Price to $290
  \u5e02\u573a\u8d44\u8baf · 2026/7/23
• Natera(NTRA.US) Director Sells US$7.01 Million in Common Stock
  \u5e02\u573a\u8d44\u8baf · 2026/9/26
• 评级变动
  Bernstein Maintains Natera(NTRA.US) With Buy Rating, Raises Target Price to $365
  \u5e02\u573a\u8d44\u8baf · 2026/9/9
• Barclays Maintains Natera(NTRA.US) With Buy Rating, Raises Target Price to $475
  \u5e02\u573a\u8d44\u8baf · 2026/10/7
• 评级变动
  Barclays Maintains Natera(NTRA.US) With Buy Rating, Maintains Target Price $340
  \u5e02\u573a\u8d44\u8baf · 2026/8/10
• Guggenheim Maintains Natera(NTRA.US) With Buy Rating, Raises Target Price to $475
  \u5e02\u573a\u8d44\u8baf · 2026/10/1
• 评级变动
  Morgan Stanley Maintains Natera(NTRA.US) With Buy Rating, Raises Target Price to $355
  \u5e02\u573a\u8d44\u8baf · 2026/8/10
• 评级变动
  Morgan Stanley Maintains Natera(NTRA.US) With Buy Rating, Maintains Target Price $355
  \u5e02\u573a\u8d44\u8baf · 2026/9/15
• 评级变动
  Jefferies Maintains Natera(NTRA.US) With Buy Rating, Raises Target Price to $330
  \u5e02\u573a\u8d44\u8baf · 2026/8/17
• 评级变动
  Citi Maintains Natera(NTRA.US) With Buy Rating, Raises Target Price to $365
  \u5e02\u573a\u8d44\u8baf · 2026/8/14
• 评级变动
  Rothschild & Co Redburn Initiates Natera(NTRA.US) With Buy Rating, Announces Target Price $385
  \u5e02\u573a\u8d44\u8baf · 2026/9/8
• 评级变动
  Bernstein Maintains Natera(NTRA.US) With Buy Rating, Maintains Target Price $310
  \u5e02\u573a\u8d44\u8baf · 2026/7/23
• RBC Capital Maintains Natera(NTRA.US) With Buy Rating, Raises Target Price to $460
  \u5e02\u573a\u8d44\u8baf · 2026/9/25
• 评级变动
  A Quick Look at Today's Ratings for Natera(NTRA.US), With a Forecast Between $284 to $375
  \u5e02\u573a\u8d44\u8baf · 2026/8/8
• 评级变动
  Goldman Sachs Maintains Natera(NTRA.US) With Hold Rating, Raises Target Price to $375
  \u5e02\u573a\u8d44\u8baf · 2026/9/21
• 评级变动
  Piper Sandler Maintains Natera(NTRA.US) With Buy Rating, Maintains Target Price $363.5
  \u5e02\u573a\u8d44\u8baf · 2026/8/24
• 评级变动
  Guggenheim Maintains Natera(NTRA.US) With Buy Rating, Raises Target Price to $360
  \u5e02\u573a\u8d44\u8baf · 2026/8/12
• 评级变动
  J.P. Morgan Maintains Natera(NTRA.US) With Buy Rating, Raises Target Price to $315
  \u5e02\u573a\u8d44\u8baf · 2026/7/22
• 评级变动
  Piper Sandler Maintains Natera(NTRA.US) With Buy Rating, Raises Target Price to $363.5
  \u5e02\u573a\u8d44\u8baf · 2026/8/12
• 评级变动
  TD Cowen Maintains Natera(NTRA.US) With Buy Rating, Raises Target Price to $325
  \u5e02\u573a\u8d44\u8baf · 2026/7/15
• Natera(NTRA.US) Director Sells US$3.22 Million in Common Stock
  \u5e02\u573a\u8d44\u8baf · 2026/9/18
• Form 144 | Natera(NTRA.US) Director Proposes to Sell 8.16 Million in Common Stocks
  \u5e02\u573a\u8d44\u8baf · 2026/9/23

新闻标题为自动聚合内容，未经我们团队独立核实或编辑。